nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP3A4—Thiotepa—sarcoma	0.132	0.178	CbGbCtD
Sitagliptin—ABCB1—Dactinomycin—sarcoma	0.106	0.143	CbGbCtD
Sitagliptin—ABCB1—Mitoxantrone—sarcoma	0.0947	0.128	CbGbCtD
Sitagliptin—CYP2C8—Etoposide—sarcoma	0.0883	0.119	CbGbCtD
Sitagliptin—ABCB1—Vincristine—sarcoma	0.0652	0.0878	CbGbCtD
Sitagliptin—ABCB1—Etoposide—sarcoma	0.0597	0.0805	CbGbCtD
Sitagliptin—CYP3A4—Mitoxantrone—sarcoma	0.0568	0.0764	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—sarcoma	0.0408	0.0549	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—sarcoma	0.0391	0.0526	CbGbCtD
Sitagliptin—CYP3A4—Etoposide—sarcoma	0.0358	0.0482	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—sarcoma	0.0244	0.0329	CbGbCtD
Sitagliptin—DPP4—embryo—sarcoma	0.000809	0.084	CbGeAlD
Sitagliptin—DPP4—seminal vesicle—sarcoma	0.00076	0.0789	CbGeAlD
Sitagliptin—DPP4—hematopoietic system—sarcoma	0.000722	0.075	CbGeAlD
Sitagliptin—DPP4—connective tissue—sarcoma	0.000695	0.0722	CbGeAlD
Sitagliptin—DPP4—smooth muscle tissue—sarcoma	0.000636	0.066	CbGeAlD
Sitagliptin—Osteoarthritis—Epirubicin—sarcoma	0.000625	0.00252	CcSEcCtD
Sitagliptin—Feeling abnormal—Dactinomycin—sarcoma	0.000624	0.00252	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Thiotepa—sarcoma	0.000624	0.00252	CcSEcCtD
Sitagliptin—Ill-defined disorder—Etoposide—sarcoma	0.000623	0.00251	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dactinomycin—sarcoma	0.000619	0.0025	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vincristine—sarcoma	0.000616	0.00249	CcSEcCtD
Sitagliptin—Migraine—Epirubicin—sarcoma	0.000615	0.00248	CcSEcCtD
Sitagliptin—Insomnia—Vincristine—sarcoma	0.000612	0.00247	CcSEcCtD
Sitagliptin—Renal impairment—Doxorubicin—sarcoma	0.000607	0.00245	CcSEcCtD
Sitagliptin—Urticaria—Thiotepa—sarcoma	0.000606	0.00245	CcSEcCtD
Sitagliptin—Malaise—Etoposide—sarcoma	0.000605	0.00244	CcSEcCtD
Sitagliptin—Face oedema—Epirubicin—sarcoma	0.000603	0.00243	CcSEcCtD
Sitagliptin—Vertigo—Etoposide—sarcoma	0.000603	0.00243	CcSEcCtD
Sitagliptin—Abdominal pain—Thiotepa—sarcoma	0.000603	0.00243	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.0006	0.00242	CcSEcCtD
Sitagliptin—Abdominal pain—Dactinomycin—sarcoma	0.000598	0.00242	CcSEcCtD
Sitagliptin—Hypoglycaemia—Doxorubicin—sarcoma	0.000592	0.00239	CcSEcCtD
Sitagliptin—Decreased appetite—Vincristine—sarcoma	0.000588	0.00237	CcSEcCtD
Sitagliptin—Cough—Etoposide—sarcoma	0.000586	0.00236	CcSEcCtD
Sitagliptin—Somnolence—Mitoxantrone—sarcoma	0.000585	0.00236	CcSEcCtD
Sitagliptin—Blood creatinine increased—Epirubicin—sarcoma	0.000585	0.00236	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vincristine—sarcoma	0.000584	0.00236	CcSEcCtD
Sitagliptin—Fatigue—Vincristine—sarcoma	0.000583	0.00235	CcSEcCtD
Sitagliptin—Dyspepsia—Mitoxantrone—sarcoma	0.00058	0.00234	CcSEcCtD
Sitagliptin—Hypertension—Etoposide—sarcoma	0.000579	0.00234	CcSEcCtD
Sitagliptin—Constipation—Vincristine—sarcoma	0.000578	0.00233	CcSEcCtD
Sitagliptin—Pain—Vincristine—sarcoma	0.000578	0.00233	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—sarcoma	0.000578	0.00233	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—sarcoma	0.000578	0.00233	CcSEcCtD
Sitagliptin—Decreased appetite—Mitoxantrone—sarcoma	0.000572	0.00231	CcSEcCtD
Sitagliptin—Abdominal pain upper—Epirubicin—sarcoma	0.000571	0.0023	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Epirubicin—sarcoma	0.000571	0.0023	CcSEcCtD
Sitagliptin—CYP2C8—mammary gland—sarcoma	0.00057	0.0592	CbGeAlD
Sitagliptin—Migraine—Doxorubicin—sarcoma	0.000569	0.0023	CcSEcCtD
Sitagliptin—Fatigue—Mitoxantrone—sarcoma	0.000568	0.00229	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000567	0.00229	CcSEcCtD
Sitagliptin—Discomfort—Etoposide—sarcoma	0.000565	0.00228	CcSEcCtD
Sitagliptin—Breast disorder—Epirubicin—sarcoma	0.000565	0.00228	CcSEcCtD
Sitagliptin—Pain—Mitoxantrone—sarcoma	0.000563	0.00227	CcSEcCtD
Sitagliptin—Constipation—Mitoxantrone—sarcoma	0.000563	0.00227	CcSEcCtD
Sitagliptin—Hypersensitivity—Thiotepa—sarcoma	0.000562	0.00227	CcSEcCtD
Sitagliptin—Nasopharyngitis—Epirubicin—sarcoma	0.000559	0.00226	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—sarcoma	0.000558	0.00225	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—sarcoma	0.000558	0.00225	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vincristine—sarcoma	0.000553	0.00223	CcSEcCtD
Sitagliptin—Anaphylactic shock—Etoposide—sarcoma	0.000548	0.00221	CcSEcCtD
Sitagliptin—Asthenia—Thiotepa—sarcoma	0.000547	0.00221	CcSEcCtD
Sitagliptin—DPP4—uterus—sarcoma	0.000545	0.0566	CbGeAlD
Sitagliptin—Infection—Etoposide—sarcoma	0.000544	0.0022	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—sarcoma	0.000543	0.00219	CcSEcCtD
Sitagliptin—Feeling abnormal—Mitoxantrone—sarcoma	0.000543	0.00219	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—sarcoma	0.000542	0.00219	CcSEcCtD
Sitagliptin—Influenza—Epirubicin—sarcoma	0.00054	0.00218	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000539	0.00217	CcSEcCtD
Sitagliptin—Abdominal pain—Vincristine—sarcoma	0.000535	0.00216	CcSEcCtD
Sitagliptin—Skin disorder—Etoposide—sarcoma	0.000532	0.00215	CcSEcCtD
Sitagliptin—Pancreatitis—Epirubicin—sarcoma	0.000529	0.00214	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—sarcoma	0.000528	0.00213	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—sarcoma	0.000528	0.00213	CcSEcCtD
Sitagliptin—Urticaria—Mitoxantrone—sarcoma	0.000523	0.00211	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—sarcoma	0.000522	0.00211	CcSEcCtD
Sitagliptin—Diarrhoea—Thiotepa—sarcoma	0.000522	0.00211	CcSEcCtD
Sitagliptin—Abdominal pain—Mitoxantrone—sarcoma	0.000521	0.0021	CcSEcCtD
Sitagliptin—Bronchitis—Epirubicin—sarcoma	0.000519	0.0021	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—sarcoma	0.000518	0.00209	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—sarcoma	0.000517	0.00209	CcSEcCtD
Sitagliptin—DPP4—lymphoid tissue—sarcoma	0.000508	0.0528	CbGeAlD
Sitagliptin—Dizziness—Thiotepa—sarcoma	0.000504	0.00204	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Epirubicin—sarcoma	0.000502	0.00203	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—sarcoma	0.0005	0.00202	CcSEcCtD
Sitagliptin—Hypersensitivity—Vincristine—sarcoma	0.000498	0.00201	CcSEcCtD
Sitagliptin—Weight increased—Epirubicin—sarcoma	0.000491	0.00198	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—sarcoma	0.00049	0.00198	CcSEcCtD
Sitagliptin—Hyperglycaemia—Epirubicin—sarcoma	0.000487	0.00197	CcSEcCtD
Sitagliptin—Somnolence—Etoposide—sarcoma	0.000487	0.00197	CcSEcCtD
Sitagliptin—Hypersensitivity—Mitoxantrone—sarcoma	0.000485	0.00196	CcSEcCtD
Sitagliptin—Asthenia—Vincristine—sarcoma	0.000485	0.00196	CcSEcCtD
Sitagliptin—Vomiting—Thiotepa—sarcoma	0.000485	0.00196	CcSEcCtD
Sitagliptin—Pneumonia—Epirubicin—sarcoma	0.000484	0.00195	CcSEcCtD
Sitagliptin—Infestation NOS—Epirubicin—sarcoma	0.000481	0.00194	CcSEcCtD
Sitagliptin—Infestation—Epirubicin—sarcoma	0.000481	0.00194	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—sarcoma	0.000481	0.00194	CcSEcCtD
Sitagliptin—Rash—Thiotepa—sarcoma	0.000481	0.00194	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—sarcoma	0.00048	0.00194	CcSEcCtD
Sitagliptin—Dermatitis—Thiotepa—sarcoma	0.00048	0.00194	CcSEcCtD
Sitagliptin—DPP4—tendon—sarcoma	0.000478	0.0496	CbGeAlD
Sitagliptin—Headache—Thiotepa—sarcoma	0.000478	0.00193	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000477	0.00193	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—sarcoma	0.000477	0.00193	CcSEcCtD
Sitagliptin—Decreased appetite—Etoposide—sarcoma	0.000476	0.00192	CcSEcCtD
Sitagliptin—Renal failure—Epirubicin—sarcoma	0.000473	0.00191	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Etoposide—sarcoma	0.000473	0.00191	CcSEcCtD
Sitagliptin—Asthenia—Mitoxantrone—sarcoma	0.000472	0.00191	CcSEcCtD
Sitagliptin—Fatigue—Etoposide—sarcoma	0.000472	0.00191	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Epirubicin—sarcoma	0.000472	0.00191	CcSEcCtD
Sitagliptin—Pain—Etoposide—sarcoma	0.000468	0.00189	CcSEcCtD
Sitagliptin—Constipation—Etoposide—sarcoma	0.000468	0.00189	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—sarcoma	0.000468	0.00189	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000464	0.00187	CcSEcCtD
Sitagliptin—DPP4—bone marrow—sarcoma	0.000463	0.0481	CbGeAlD
Sitagliptin—Diarrhoea—Vincristine—sarcoma	0.000463	0.00187	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—sarcoma	0.000455	0.00184	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—sarcoma	0.000455	0.00184	CcSEcCtD
Sitagliptin—Nausea—Thiotepa—sarcoma	0.000453	0.00183	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—sarcoma	0.000452	0.00182	CcSEcCtD
Sitagliptin—Feeling abnormal—Etoposide—sarcoma	0.000451	0.00182	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—sarcoma	0.000451	0.00182	CcSEcCtD
Sitagliptin—Diarrhoea—Mitoxantrone—sarcoma	0.000451	0.00182	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—sarcoma	0.00045	0.00181	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—sarcoma	0.000448	0.00181	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Etoposide—sarcoma	0.000448	0.00181	CcSEcCtD
Sitagliptin—Dizziness—Vincristine—sarcoma	0.000447	0.00181	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—sarcoma	0.000445	0.0018	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—sarcoma	0.000445	0.0018	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000442	0.00178	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—sarcoma	0.000438	0.00177	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000437	0.00176	CcSEcCtD
Sitagliptin—Urticaria—Etoposide—sarcoma	0.000435	0.00176	CcSEcCtD
Sitagliptin—Abdominal pain—Etoposide—sarcoma	0.000433	0.00175	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—sarcoma	0.000433	0.00175	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—sarcoma	0.00043	0.00174	CcSEcCtD
Sitagliptin—Vomiting—Vincristine—sarcoma	0.00043	0.00174	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—sarcoma	0.000429	0.00173	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—sarcoma	0.000427	0.00172	CcSEcCtD
Sitagliptin—Rash—Vincristine—sarcoma	0.000426	0.00172	CcSEcCtD
Sitagliptin—Dermatitis—Vincristine—sarcoma	0.000426	0.00172	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—sarcoma	0.000426	0.00172	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—sarcoma	0.000425	0.00171	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—sarcoma	0.000424	0.00171	CcSEcCtD
Sitagliptin—Headache—Vincristine—sarcoma	0.000424	0.00171	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—sarcoma	0.000421	0.0017	CcSEcCtD
Sitagliptin—Vomiting—Mitoxantrone—sarcoma	0.000419	0.00169	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—sarcoma	0.000418	0.00169	CcSEcCtD
Sitagliptin—Rash—Mitoxantrone—sarcoma	0.000415	0.00168	CcSEcCtD
Sitagliptin—Dermatitis—Mitoxantrone—sarcoma	0.000415	0.00167	CcSEcCtD
Sitagliptin—Headache—Mitoxantrone—sarcoma	0.000413	0.00167	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—sarcoma	0.000409	0.00165	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—sarcoma	0.000404	0.00163	CcSEcCtD
Sitagliptin—Hypersensitivity—Etoposide—sarcoma	0.000404	0.00163	CcSEcCtD
Sitagliptin—Nausea—Vincristine—sarcoma	0.000402	0.00162	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—sarcoma	0.000401	0.00162	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—sarcoma	0.000398	0.00161	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—sarcoma	0.000397	0.0016	CcSEcCtD
Sitagliptin—DPP4—testis—sarcoma	0.000396	0.0411	CbGeAlD
Sitagliptin—Urinary tract disorder—Doxorubicin—sarcoma	0.000395	0.00159	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—sarcoma	0.000394	0.00159	CcSEcCtD
Sitagliptin—Asthenia—Etoposide—sarcoma	0.000393	0.00159	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—sarcoma	0.000393	0.00159	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—sarcoma	0.000392	0.00158	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—sarcoma	0.000392	0.00158	CcSEcCtD
Sitagliptin—Nausea—Mitoxantrone—sarcoma	0.000391	0.00158	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—sarcoma	0.00039	0.00158	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—sarcoma	0.00039	0.00157	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—sarcoma	0.000379	0.00153	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—sarcoma	0.000378	0.00153	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—sarcoma	0.000376	0.00152	CcSEcCtD
Sitagliptin—Diarrhoea—Etoposide—sarcoma	0.000375	0.00151	CcSEcCtD
Sitagliptin—DPP4—liver—sarcoma	0.000374	0.0388	CbGeAlD
Sitagliptin—Eye disorder—Doxorubicin—sarcoma	0.000374	0.00151	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—sarcoma	0.000371	0.0015	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—sarcoma	0.000371	0.0015	CcSEcCtD
Sitagliptin—Tension—Epirubicin—sarcoma	0.000369	0.00149	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—sarcoma	0.000365	0.00148	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—sarcoma	0.000364	0.00147	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—sarcoma	0.000363	0.00146	CcSEcCtD
Sitagliptin—Dizziness—Etoposide—sarcoma	0.000362	0.00146	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—sarcoma	0.000362	0.00146	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—sarcoma	0.000361	0.00146	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—sarcoma	0.00036	0.00145	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—sarcoma	0.000355	0.00143	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—sarcoma	0.00035	0.00141	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—sarcoma	0.000349	0.00141	CcSEcCtD
Sitagliptin—Vomiting—Etoposide—sarcoma	0.000348	0.00141	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—sarcoma	0.000348	0.00141	CcSEcCtD
Sitagliptin—CYP2C8—hematopoietic system—sarcoma	0.000348	0.0361	CbGeAlD
Sitagliptin—Rash—Etoposide—sarcoma	0.000345	0.00139	CcSEcCtD
Sitagliptin—Dermatitis—Etoposide—sarcoma	0.000345	0.00139	CcSEcCtD
Sitagliptin—Headache—Etoposide—sarcoma	0.000343	0.00139	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—sarcoma	0.000343	0.00138	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—sarcoma	0.000342	0.00138	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—sarcoma	0.000339	0.00137	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—sarcoma	0.000338	0.00136	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—sarcoma	0.000338	0.00136	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—sarcoma	0.000337	0.00136	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—sarcoma	0.000335	0.00135	CcSEcCtD
Sitagliptin—Cough—Epirubicin—sarcoma	0.000328	0.00133	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—sarcoma	0.000328	0.00132	CcSEcCtD
Sitagliptin—Nausea—Etoposide—sarcoma	0.000325	0.00131	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—sarcoma	0.000325	0.00131	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—sarcoma	0.000323	0.0013	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—sarcoma	0.00032	0.00129	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—sarcoma	0.00032	0.00129	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—sarcoma	0.000319	0.00129	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000318	0.00128	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—sarcoma	0.000316	0.00128	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—sarcoma	0.000314	0.00127	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—sarcoma	0.000313	0.00126	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—sarcoma	0.000313	0.00126	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—sarcoma	0.000307	0.00124	CcSEcCtD
Sitagliptin—Infection—Epirubicin—sarcoma	0.000305	0.00123	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—sarcoma	0.000304	0.00123	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—sarcoma	0.000301	0.00122	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—sarcoma	0.000301	0.00121	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—sarcoma	0.000298	0.0012	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—sarcoma	0.000296	0.0012	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—sarcoma	0.000296	0.0012	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—sarcoma	0.000295	0.00119	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000294	0.00119	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—sarcoma	0.000293	0.00118	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—sarcoma	0.00029	0.00117	CcSEcCtD
Sitagliptin—DPP4—lymph node—sarcoma	0.000287	0.0298	CbGeAlD
Sitagliptin—Anaphylactic shock—Doxorubicin—sarcoma	0.000284	0.00115	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—sarcoma	0.000282	0.00114	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00028	0.00113	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—sarcoma	0.000279	0.00112	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—sarcoma	0.000278	0.00112	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—sarcoma	0.000276	0.00111	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—sarcoma	0.000273	0.0011	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—sarcoma	0.00027	0.00109	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—sarcoma	0.000267	0.00108	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000265	0.00107	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—sarcoma	0.000265	0.00107	CcSEcCtD
Sitagliptin—Pain—Epirubicin—sarcoma	0.000263	0.00106	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—sarcoma	0.000263	0.00106	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000259	0.00104	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—sarcoma	0.000257	0.00104	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—sarcoma	0.000253	0.00102	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—sarcoma	0.000253	0.00102	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—sarcoma	0.000251	0.00101	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—sarcoma	0.00025	0.00101	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—sarcoma	0.000247	0.000997	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000245	0.00099	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—sarcoma	0.000245	0.000989	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—sarcoma	0.000244	0.000985	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—sarcoma	0.000243	0.000981	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—sarcoma	0.000243	0.000981	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—sarcoma	0.000243	0.00098	CcSEcCtD
Sitagliptin—CYP3A4—hematopoietic system—sarcoma	0.000235	0.0244	CbGeAlD
Sitagliptin—Feeling abnormal—Doxorubicin—sarcoma	0.000234	0.000945	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000232	0.000938	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—sarcoma	0.000226	0.000913	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—sarcoma	0.000226	0.000911	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—sarcoma	0.000225	0.000907	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—sarcoma	0.00022	0.000889	CcSEcCtD
Sitagliptin—Diarrhoea—Epirubicin—sarcoma	0.00021	0.000848	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—sarcoma	0.000209	0.000845	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—sarcoma	0.000204	0.000823	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—sarcoma	0.000203	0.00082	CcSEcCtD
Sitagliptin—Vomiting—Epirubicin—sarcoma	0.000195	0.000788	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—sarcoma	0.000194	0.000785	CcSEcCtD
Sitagliptin—ABCB1—myometrium—sarcoma	0.000194	0.0202	CbGeAlD
Sitagliptin—Rash—Epirubicin—sarcoma	0.000194	0.000782	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—sarcoma	0.000193	0.000781	CcSEcCtD
Sitagliptin—Headache—Epirubicin—sarcoma	0.000192	0.000777	CcSEcCtD
Sitagliptin—CYP2C8—testis—sarcoma	0.00019	0.0198	CbGeAlD
Sitagliptin—Dizziness—Doxorubicin—sarcoma	0.000188	0.000758	CcSEcCtD
Sitagliptin—ABCB1—embryo—sarcoma	0.000187	0.0194	CbGeAlD
Sitagliptin—Nausea—Epirubicin—sarcoma	0.000182	0.000736	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—sarcoma	0.000181	0.000729	CcSEcCtD
Sitagliptin—CYP2C8—liver—sarcoma	0.00018	0.0187	CbGeAlD
Sitagliptin—Rash—Doxorubicin—sarcoma	0.000179	0.000723	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—sarcoma	0.000179	0.000723	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—sarcoma	0.000178	0.000719	CcSEcCtD
Sitagliptin—ABCB1—seminal vesicle—sarcoma	0.000175	0.0182	CbGeAlD
Sitagliptin—Nausea—Doxorubicin—sarcoma	0.000169	0.000681	CcSEcCtD
Sitagliptin—ABCB1—hematopoietic system—sarcoma	0.000167	0.0173	CbGeAlD
Sitagliptin—ABCB1—uterus—sarcoma	0.000126	0.0131	CbGeAlD
Sitagliptin—CYP3A4—liver—sarcoma	0.000122	0.0127	CbGeAlD
Sitagliptin—ABCB1—lymphoid tissue—sarcoma	0.000117	0.0122	CbGeAlD
Sitagliptin—ABCB1—bone marrow—sarcoma	0.000107	0.0111	CbGeAlD
Sitagliptin—ABCB1—testis—sarcoma	9.13e-05	0.00948	CbGeAlD
Sitagliptin—ABCB1—liver—sarcoma	8.63e-05	0.00896	CbGeAlD
Sitagliptin—ABCB1—lymph node—sarcoma	6.62e-05	0.00687	CbGeAlD
